Artículos

Bone mineral density and osteoporosis risk in older patients with schizophrenia / Do Un Jung en Journal of Clinical Psychopharmacology, Año 2011 - Vol. 31 - No. 4 (Agosto)

Público ISBD [artículo]  inJournal of Clinical Psychopharmacology > Año 2011 - Vol. 31 - No. 4 (Agosto) . - pp. 406-410 Título : Bone mineral density and osteoporosis risk in older patients with schizophrenia Tipo de documento: texto impreso Autores: Do Un Jung, Autor ; Deanna L. Kelly, Autor ; Min Kyung Oh, Autor Fecha de publicación: 2022 Artículo en la página: pp. 406-410 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Esquizofrenia, Densidad mineral ósea, Osteoporosis, Fractura Resumen: People with schizophrenia are at a higher risk for osteoporosis. The authors investigated the prevalence of low bone density and its risk factors in older Korean patients with schizophrenia. Link: ./index.php?lvl=notice_display&id=29358 [artículo] Bone mineral density and osteoporosis risk in older patients with schizophrenia [texto impreso] / Do Un Jung, Autor ; Deanna L. Kelly, Autor ; Min Kyung Oh, Autor . - 2022 . - pp. 406-410. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Journal of Clinical Psychopharmacology > Año 2011 - Vol. 31 - No. 4 (Agosto) . - pp. 406-410 Palabras clave: Esquizofrenia, Densidad mineral ósea, Osteoporosis, Fractura Resumen: People with schizophrenia are at a higher risk for osteoporosis. The authors investigated the prevalence of low bone density and its risk factors in older Korean patients with schizophrenia. Link: ./index.php?lvl=notice_display&id=29358

Plasma olanzapine in relation to prescribed dose and other factors / Maxine X. Patel en Journal of Clinical Psychopharmacology, Año 2011 - Vol. 31 - No. 4 (Agosto)

Público ISBD [artículo]  inJournal of Clinical Psychopharmacology > Año 2011 - Vol. 31 - No. 4 (Agosto) . - pp. 411-417 Título : Plasma olanzapine in relation to prescribed dose and other factors : data from a therapeutic drug monitoring service, 1999-2009 Tipo de documento: texto impreso Autores: Maxine X. Patel, Autor ; Sally MRes Bowskill, Autor ; Lewis Couchman, Autor Fecha de publicación: 2022 Artículo en la página: pp. 411-417 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Olanzapina - monitorización de fármacos terapéuticos, Olanzapina - adherencia, Olanzapina - relación dosis concentración plasmática, olanzapina - predicción de dosis Resumen: Olanzapine therapeutic drug monitoring (TDM) is the measurement of plasma olanzapine to assess adherence and guide dosage. We have audited data from an olanzapine TDM service, 1999-2009. Multiple linear regression analysis was conducted to investigate the contribution of dose, age, sex, body weight, and smoking status to the plasma olanzapine concentration. Link: ./index.php?lvl=notice_display&id=29359 [artículo] Plasma olanzapine in relation to prescribed dose and other factors : data from a therapeutic drug monitoring service, 1999-2009 [texto impreso] / Maxine X. Patel, Autor ; Sally MRes Bowskill, Autor ; Lewis Couchman, Autor . - 2022 . - pp. 411-417. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Journal of Clinical Psychopharmacology > Año 2011 - Vol. 31 - No. 4 (Agosto) . - pp. 411-417 Palabras clave: Olanzapina - monitorización de fármacos terapéuticos, Olanzapina - adherencia, Olanzapina - relación dosis concentración plasmática, olanzapina - predicción de dosis Resumen: Olanzapine therapeutic drug monitoring (TDM) is the measurement of plasma olanzapine to assess adherence and guide dosage. We have audited data from an olanzapine TDM service, 1999-2009. Multiple linear regression analysis was conducted to investigate the contribution of dose, age, sex, body weight, and smoking status to the plasma olanzapine concentration. Link: ./index.php?lvl=notice_display&id=29359

A randomized, double-blind study of once-daily extended release quetiapine fumarate (quetiapine xr) monotherapy in patients with generalized anxiety disorder / Arifulla Khan en Journal of Clinical Psychopharmacology, Año 2011 - Vol. 31 - No. 4 (Agosto)

Público ISBD [artículo]  inJournal of Clinical Psychopharmacology > Año 2011 - Vol. 31 - No. 4 (Agosto) . - PP. 418-428 Título : A randomized, double-blind study of once-daily extended release quetiapine fumarate (quetiapine xr) monotherapy in patients with generalized anxiety disorder Tipo de documento: texto impreso Autores: Arifulla Khan, Autor ; Mark Joyce, Autor ; Sarah Atkinson, Autor Fecha de publicación: 2022 Artículo en la página: PP. 418-428 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Agentes ansiolíticos, Agentes antipsicóticos, Ensayo clínico, Fumarato de quetiapina de liberación prolongada, Placebo, Multicéntrico, Estudio de fase 3 Resumen: This study evaluated once-daily, extended-release quetiapine fumarate (quetiapine XR) monotherapy in generalized anxiety disorder (GAD). This was a 10-week (8-week active treatment/2-week posttreatment drug-discontinuation/tapering phase), double-blind, randomized, placebo-controlled study (D1448C00009). Primary end point was change from randomization at week 8 in Hamilton Anxiety Rating Scale (HAM-A) total score. Link: ./index.php?lvl=notice_display&id=29360 [artículo] A randomized, double-blind study of once-daily extended release quetiapine fumarate (quetiapine xr) monotherapy in patients with generalized anxiety disorder [texto impreso] / Arifulla Khan, Autor ; Mark Joyce, Autor ; Sarah Atkinson, Autor . - 2022 . - PP. 418-428. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Journal of Clinical Psychopharmacology > Año 2011 - Vol. 31 - No. 4 (Agosto) . - PP. 418-428 Palabras clave: Agentes ansiolíticos, Agentes antipsicóticos, Ensayo clínico, Fumarato de quetiapina de liberación prolongada, Placebo, Multicéntrico, Estudio de fase 3 Resumen: This study evaluated once-daily, extended-release quetiapine fumarate (quetiapine XR) monotherapy in generalized anxiety disorder (GAD). This was a 10-week (8-week active treatment/2-week posttreatment drug-discontinuation/tapering phase), double-blind, randomized, placebo-controlled study (D1448C00009). Primary end point was change from randomization at week 8 in Hamilton Anxiety Rating Scale (HAM-A) total score. Link: ./index.php?lvl=notice_display&id=29360

Antidepressant use and cognitive functioning in older medical patients with major or minor depression / Ling Han en Journal of Clinical Psychopharmacology, Año 2011 - Vol. 31 - No. 4 (Agosto)

Público ISBD [artículo]  inJournal of Clinical Psychopharmacology > Año 2011 - Vol. 31 - No. 4 (Agosto) . - pp. 429-435 Título : Antidepressant use and cognitive functioning in older medical patients with major or minor depression : A prospective cohort study with database linkage Tipo de documento: texto impreso Autores: Ling Han, Autor ; Jane McCusker, Autor ; Martin Cole, Autor Fecha de publicación: 2022 Artículo en la página: pp. 429-435 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Antidepresivos, Depresión menor, Función cognitiva, Adultos mayores, Pacientes médicos Resumen: The long-term cognitive effect of antidepressant medications in older persons is not well understood, especially in those with minor depression and complex medical conditions. The objective of this study is to examine this relationship in older medical patients with different depression diagnoses. Link: ./index.php?lvl=notice_display&id=29361 [artículo] Antidepressant use and cognitive functioning in older medical patients with major or minor depression : A prospective cohort study with database linkage [texto impreso] / Ling Han, Autor ; Jane McCusker, Autor ; Martin Cole, Autor . - 2022 . - pp. 429-435. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Journal of Clinical Psychopharmacology > Año 2011 - Vol. 31 - No. 4 (Agosto) . - pp. 429-435 Palabras clave: Antidepresivos, Depresión menor, Función cognitiva, Adultos mayores, Pacientes médicos Resumen: The long-term cognitive effect of antidepressant medications in older persons is not well understood, especially in those with minor depression and complex medical conditions. The objective of this study is to examine this relationship in older medical patients with different depression diagnoses. Link: ./index.php?lvl=notice_display&id=29361

Efficacy and safety of mifepristone for the treatment of psychotic depression / Christine Blasey en Journal of Clinical Psychopharmacology, Año 2011 - Vol. 31 - No. 4 (Agosto)

Público ISBD [artículo]  inJournal of Clinical Psychopharmacology > Año 2011 - Vol. 31 - No. 4 (Agosto) . - pp. 436-440 Título : Efficacy and safety of mifepristone for the treatment of psychotic depression Tipo de documento: texto impreso Autores: Christine Blasey, Autor ; Thaddeus S. Block, Autor ; Joseph K. Belanoff, Autor Fecha de publicación: 2022 Artículo en la página: pp. 436-440 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Depresión psicótica, Antagonistas de los receptores de glucocorticoides, Mifepristona, Cortisol, Eje hipotálamo-pituitario-suprarrenal, Análisis ROC, Detección de señales Resumen: Open-label studies and randomized clinical trials have suggested that mifepristone may be effective for the treatment of major depression with psychotic features (psychotic depression). A recent study reported a correlation between mifepristone plasma concentration and clinical response. Link: ./index.php?lvl=notice_display&id=29362 [artículo] Efficacy and safety of mifepristone for the treatment of psychotic depression [texto impreso] / Christine Blasey, Autor ; Thaddeus S. Block, Autor ; Joseph K. Belanoff, Autor . - 2022 . - pp. 436-440. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Journal of Clinical Psychopharmacology > Año 2011 - Vol. 31 - No. 4 (Agosto) . - pp. 436-440 Palabras clave: Depresión psicótica, Antagonistas de los receptores de glucocorticoides, Mifepristona, Cortisol, Eje hipotálamo-pituitario-suprarrenal, Análisis ROC, Detección de señales Resumen: Open-label studies and randomized clinical trials have suggested that mifepristone may be effective for the treatment of major depression with psychotic features (psychotic depression). A recent study reported a correlation between mifepristone plasma concentration and clinical response. Link: ./index.php?lvl=notice_display&id=29362

Absence of psychostimulant effects of a supratherapeutic dose of tianeptine / Katy Bernard en Journal of Clinical Psychopharmacology, Año 2011 - Vol. 31 - No. 4 (Agosto)

Público ISBD [artículo]  inJournal of Clinical Psychopharmacology > Año 2011 - Vol. 31 - No. 4 (Agosto) . - pp. 441-448 Título : Absence of psychostimulant effects of a supratherapeutic dose of tianeptine : A placebo controlled study versus methylphenidate in young healthy volunteers Tipo de documento: texto impreso Autores: Katy Bernard, Autor ; Pierre François Penelaud, Autor ; Elisabeth Mocaër, Autor Fecha de publicación: 2022 Artículo en la página: pp. 441-448 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Tianeptina, Metilfenidato, Voluntaria sana, ARCI Resumen: The primary objective of the present study was to assess the potential psychostimulant effect of a single oral supratherapeutic dose of tianeptine (75 mg in 1 shot) in young healthy volunteers compared with methylphenidate (40 mg) and placebo. Link: ./index.php?lvl=notice_display&id=29363 [artículo] Absence of psychostimulant effects of a supratherapeutic dose of tianeptine : A placebo controlled study versus methylphenidate in young healthy volunteers [texto impreso] / Katy Bernard, Autor ; Pierre François Penelaud, Autor ; Elisabeth Mocaër, Autor . - 2022 . - pp. 441-448. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Journal of Clinical Psychopharmacology > Año 2011 - Vol. 31 - No. 4 (Agosto) . - pp. 441-448 Palabras clave: Tianeptina, Metilfenidato, Voluntaria sana, ARCI Resumen: The primary objective of the present study was to assess the potential psychostimulant effect of a single oral supratherapeutic dose of tianeptine (75 mg in 1 shot) in young healthy volunteers compared with methylphenidate (40 mg) and placebo. Link: ./index.php?lvl=notice_display&id=29363

Relationship between a history of a suicide attempt and treatment outcomes in patients with depression / Sung-Wan Kim en Journal of Clinical Psychopharmacology, Año 2011 - Vol. 31 - No. 4 (Agosto)

Público ISBD [artículo]  inJournal of Clinical Psychopharmacology > Año 2011 - Vol. 31 - No. 4 (Agosto) . - pp. 449-456 Título : Relationship between a history of a suicide attempt and treatment outcomes in patients with depression Tipo de documento: texto impreso Autores: Sung-Wan Kim, Autor ; Robert Stewart, Autor ; Jae-Min Kim, Autor Fecha de publicación: 2022 Artículo en la página: pp. 449-456 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Suicidio, Intentos de suicidio, Depresión, Remisión, CRESCEND Resumen: This study aimed to investigate the sociodemographic and clinical correlates of a history of a suicide attempt in people with depression and their relationship with treatment outcomes and subsequent suicidal ideation and deliberate self-harm. Patients with depressive disorders according to the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, were recruited from 18 hospitals across South Korea. Link: ./index.php?lvl=notice_display&id=29364 [artículo] Relationship between a history of a suicide attempt and treatment outcomes in patients with depression [texto impreso] / Sung-Wan Kim, Autor ; Robert Stewart, Autor ; Jae-Min Kim, Autor . - 2022 . - pp. 449-456. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Journal of Clinical Psychopharmacology > Año 2011 - Vol. 31 - No. 4 (Agosto) . - pp. 449-456 Palabras clave: Suicidio, Intentos de suicidio, Depresión, Remisión, CRESCEND Resumen: This study aimed to investigate the sociodemographic and clinical correlates of a history of a suicide attempt in people with depression and their relationship with treatment outcomes and subsequent suicidal ideation and deliberate self-harm. Patients with depressive disorders according to the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, were recruited from 18 hospitals across South Korea. Link: ./index.php?lvl=notice_display&id=29364

Prevalence and psychological impact of antidepressant-associated sexual dysfunction / Kodakandla Krishna en Journal of Clinical Psychopharmacology, Año 2011 - Vol. 31 - No. 4 (Agosto)

Público ISBD [artículo]  inJournal of Clinical Psychopharmacology > Año 2011 - Vol. 31 - No. 4 (Agosto) . - PP. 457-462 Título : Prevalence and psychological impact of antidepressant-associated sexual dysfunction : A study from north india Tipo de documento: texto impreso Autores: Kodakandla Krishna, Autor ; Ajit Avasthi, Autor ; Sandeep Grover, Autor Fecha de publicación: 2022 Artículo en la página: PP. 457-462 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Antidepresivos, Disfunción sexual, Calidad de vida, Cumplimiento Resumen: This study attempted to estimate the prevalence and impact of sexual dysfunction on quality of life, treatment compliance, and dyadic adjustment with spouse. For this, 100 consenting subjects who had history of unipolar depression (as per Mini International Neuropsychiatric Interview) and were in remission (Hamilton Depression Rating Scale, Link: ./index.php?lvl=notice_display&id=29365 [artículo] Prevalence and psychological impact of antidepressant-associated sexual dysfunction : A study from north india [texto impreso] / Kodakandla Krishna, Autor ; Ajit Avasthi, Autor ; Sandeep Grover, Autor . - 2022 . - PP. 457-462. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Journal of Clinical Psychopharmacology > Año 2011 - Vol. 31 - No. 4 (Agosto) . - PP. 457-462 Palabras clave: Antidepresivos, Disfunción sexual, Calidad de vida, Cumplimiento Resumen: This study attempted to estimate the prevalence and impact of sexual dysfunction on quality of life, treatment compliance, and dyadic adjustment with spouse. For this, 100 consenting subjects who had history of unipolar depression (as per Mini International Neuropsychiatric Interview) and were in remission (Hamilton Depression Rating Scale, Link: ./index.php?lvl=notice_display&id=29365

Cyp2b6 polymorphisms influence the plasma concentration and clearance of the methadone s-enantiomer / Sheng Chang Wang en Journal of Clinical Psychopharmacology, Año 2011 - Vol. 31 - No. 4 (Agosto)

Público ISBD [artículo]  inJournal of Clinical Psychopharmacology > Año 2011 - Vol. 31 - No. 4 (Agosto) . - pp. 463-469 Título : Cyp2b6 polymorphisms influence the plasma concentration and clearance of the methadone s-enantiomer Tipo de documento: texto impreso Autores: Sheng Chang Wang, Autor ; Ing Kang Ho, Autor ; Hsiao Hui Tsou, Autor Fecha de publicación: 2022 Artículo en la página: pp. 463-469 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: CYP2B6, Metadona, Enantiómero S., Adicción a la heroína, SNP Resumen: Methadone is a racemic compound composed of the R-form and S-form enantiomers. The drug is usually used in maintenance therapy for the heroin-addicted patients. In our previous study, we found that the cytochrome P-450 (CYP) isozyme 2B6 preferentially metabolizes the S-methadone enantiomer. Link: ./index.php?lvl=notice_display&id=29366 [artículo] Cyp2b6 polymorphisms influence the plasma concentration and clearance of the methadone s-enantiomer [texto impreso] / Sheng Chang Wang, Autor ; Ing Kang Ho, Autor ; Hsiao Hui Tsou, Autor . - 2022 . - pp. 463-469. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Journal of Clinical Psychopharmacology > Año 2011 - Vol. 31 - No. 4 (Agosto) . - pp. 463-469 Palabras clave: CYP2B6, Metadona, Enantiómero S., Adicción a la heroína, SNP Resumen: Methadone is a racemic compound composed of the R-form and S-form enantiomers. The drug is usually used in maintenance therapy for the heroin-addicted patients. In our previous study, we found that the cytochrome P-450 (CYP) isozyme 2B6 preferentially metabolizes the S-methadone enantiomer. Link: ./index.php?lvl=notice_display&id=29366

Discriminative-stimulus, subject-rated, and physiological effects of methamphetamine in humans pretreated with aripiprazole / Rajkumar J. Sevak en Journal of Clinical Psychopharmacology, Año 2011 - Vol. 31 - No. 4 (Agosto)

Público ISBD [artículo]  inJournal of Clinical Psychopharmacology > Año 2011 - Vol. 31 - No. 4 (Agosto) . - pp. 470-480 Título : Discriminative-stimulus, subject-rated, and physiological effects of methamphetamine in humans pretreated with aripiprazole Tipo de documento: texto impreso Autores: Rajkumar J. Sevak, Autor ; Andrea R. Vansickel, Autor ; William W. Stoops, Autor Fecha de publicación: 2022 Artículo en la página: pp. 470-480 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Metanfetamina, Aripiprazol, Discriminación por drogas, Abuso de estimulantes Resumen: Methamphetamine is thought to produce its behavioral effects by facilitating release of dopamine, serotonin (5-HT) and norepinephrine. Results from animal studies support this notion, whereas results from human laboratory studies have not consistently demonstrated the importance of monoamine systems in the behavioral effects of methamphetamine. Link: ./index.php?lvl=notice_display&id=29367 [artículo] Discriminative-stimulus, subject-rated, and physiological effects of methamphetamine in humans pretreated with aripiprazole [texto impreso] / Rajkumar J. Sevak, Autor ; Andrea R. Vansickel, Autor ; William W. Stoops, Autor . - 2022 . - pp. 470-480. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Journal of Clinical Psychopharmacology > Año 2011 - Vol. 31 - No. 4 (Agosto) . - pp. 470-480 Palabras clave: Metanfetamina, Aripiprazol, Discriminación por drogas, Abuso de estimulantes Resumen: Methamphetamine is thought to produce its behavioral effects by facilitating release of dopamine, serotonin (5-HT) and norepinephrine. Results from animal studies support this notion, whereas results from human laboratory studies have not consistently demonstrated the importance of monoamine systems in the behavioral effects of methamphetamine. Link: ./index.php?lvl=notice_display&id=29367

Psychomotor performance after intake of zopiclone compared with intake of ethanol / Ingebjørg Gustavsen en Journal of Clinical Psychopharmacology, Año 2011 - Vol. 31 - No. 4 (Agosto)

Público ISBD [artículo]  inJournal of Clinical Psychopharmacology > Año 2011 - Vol. 31 - No. 4 (Agosto) . - pp. 481-488 Título : Psychomotor performance after intake of zopiclone compared with intake of ethanol : A randomized, controlled, double blinded trial Tipo de documento: texto impreso Autores: Ingebjørg Gustavsen, Autor ; Knut Hjelmeland, Autor ; Jean Paul Bernard, Autor Fecha de publicación: 2022 Artículo en la página: pp. 481-488 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Zopiclona, Etanol, Desempeño psicomotor, Deterioro Resumen: The sleep medicine zopiclone (eszopiclone) is commonly used in most Western countries. The focus on legislation for possible traffic-impairing nonalcohol drugs have caused a need for comparing traffic relevant behavior after intake of commonly used psychoactive drugs to blood alcohol concentrations (BACs). We aimed to compare psychomotor effects at 3 levels of behavior at different blood zopiclone concentrations to effects seen at different BACs. Link: ./index.php?lvl=notice_display&id=29368 [artículo] Psychomotor performance after intake of zopiclone compared with intake of ethanol : A randomized, controlled, double blinded trial [texto impreso] / Ingebjørg Gustavsen, Autor ; Knut Hjelmeland, Autor ; Jean Paul Bernard, Autor . - 2022 . - pp. 481-488. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Journal of Clinical Psychopharmacology > Año 2011 - Vol. 31 - No. 4 (Agosto) . - pp. 481-488 Palabras clave: Zopiclona, Etanol, Desempeño psicomotor, Deterioro Resumen: The sleep medicine zopiclone (eszopiclone) is commonly used in most Western countries. The focus on legislation for possible traffic-impairing nonalcohol drugs have caused a need for comparing traffic relevant behavior after intake of commonly used psychoactive drugs to blood alcohol concentrations (BACs). We aimed to compare psychomotor effects at 3 levels of behavior at different blood zopiclone concentrations to effects seen at different BACs. Link: ./index.php?lvl=notice_display&id=29368

Differential effectiveness of antipsychotics in borderline personality disorder / Theo Ingenhoven en Journal of Clinical Psychopharmacology, Año 2011 - Vol. 31 - No. 4 (Agosto)

Público ISBD [artículo]  inJournal of Clinical Psychopharmacology > Año 2011 - Vol. 31 - No. 4 (Agosto) . - pp. 489-496 Título : Differential effectiveness of antipsychotics in borderline personality disorder : Meta analyses of placebo controlled, randomized clinical trials on symptomatic outcome domains Tipo de documento: texto impreso Autores: Theo Ingenhoven, Autor ; Hugo J. Duivenvoorden, Autor Fecha de publicación: 2022 Artículo en la página: pp. 489-496 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Metaanálisis, ECA, Trastorno límite de la personalidad, Farmacoterapia, Antipsicóticos Resumen: In clinical practice, antipsychotic drugs are widely used in borderline personality disorder (BPD). To evaluate current pharmacological treatment algorithms and guidelines for BPD, the authors reviewed and meta-analyzed studies on the effectiveness of antipsychotics on specific symptom domains in BPD. Link: ./index.php?lvl=notice_display&id=29369 [artículo] Differential effectiveness of antipsychotics in borderline personality disorder : Meta analyses of placebo controlled, randomized clinical trials on symptomatic outcome domains [texto impreso] / Theo Ingenhoven, Autor ; Hugo J. Duivenvoorden, Autor . - 2022 . - pp. 489-496. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Journal of Clinical Psychopharmacology > Año 2011 - Vol. 31 - No. 4 (Agosto) . - pp. 489-496 Palabras clave: Metaanálisis, ECA, Trastorno límite de la personalidad, Farmacoterapia, Antipsicóticos Resumen: In clinical practice, antipsychotic drugs are widely used in borderline personality disorder (BPD). To evaluate current pharmacological treatment algorithms and guidelines for BPD, the authors reviewed and meta-analyzed studies on the effectiveness of antipsychotics on specific symptom domains in BPD. Link: ./index.php?lvl=notice_display&id=29369

Dopamine d2 receptor occupancy and clinical effects / Hiroyuki Uchida en Journal of Clinical Psychopharmacology, Año 2011 - Vol. 31 - No. 4 (Agosto)

Público ISBD [artículo]  inJournal of Clinical Psychopharmacology > Año 2011 - Vol. 31 - No. 4 (Agosto) . - pp. 497-502 Título : Dopamine d2 receptor occupancy and clinical effects : A systematic review and pooled analysis Tipo de documento: texto impreso Autores: Hiroyuki Uchida, Autor ; Hiroyoshi Takeuchi, Autor ; Ariel Graff Guerrero, Autor Fecha de publicación: 2022 Artículo en la página: pp. 497-502 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Antipsicótico, Dopamina, Receptor de dopamina D2, Tomografía por emisión de positrones, Esquizofrenia Resumen: Positron emission tomography (PET) studies proposed a therapeutic window of D2 receptor occupancy (65%-80%) of antipsychotics for the treatment of schizophrenia in young adults. However, this conclusion has been drawn from clinical PET studies using small sample sizes ( Link: ./index.php?lvl=notice_display&id=29370 [artículo] Dopamine d2 receptor occupancy and clinical effects : A systematic review and pooled analysis [texto impreso] / Hiroyuki Uchida, Autor ; Hiroyoshi Takeuchi, Autor ; Ariel Graff Guerrero, Autor . - 2022 . - pp. 497-502. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Journal of Clinical Psychopharmacology > Año 2011 - Vol. 31 - No. 4 (Agosto) . - pp. 497-502 Palabras clave: Antipsicótico, Dopamina, Receptor de dopamina D2, Tomografía por emisión de positrones, Esquizofrenia Resumen: Positron emission tomography (PET) studies proposed a therapeutic window of D2 receptor occupancy (65%-80%) of antipsychotics for the treatment of schizophrenia in young adults. However, this conclusion has been drawn from clinical PET studies using small sample sizes ( Link: ./index.php?lvl=notice_display&id=29370